Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.010 Biomarker disease BEFREE Ibrutinib (PCI-32765) is the most advanced BTK inhibitor in clinical testing, with ongoing phase III clinical trials in patients with chronic lymphocytic leukemia and mantle-cell lymphoma. 24778403 2014